Trade Mark Journal No.2026/011 13 March 2026
UK00004345540 25 February 2026 (5)

- Class 5
- Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders.
Viridian Therapeutics, Inc.
Representative: Fox Williams LLP